BACKGROUND: The genetic identities of mucins secreted in the airways of patients with diffuse panbronchiolitis (DPB) have not been previously investigated, although hypersecretion is a common feature of this disease. OBJECTIVE: The purpose of this study was to determine the production of MUC5AC, a major core protein of mucin in airway secretion, and the effect of macrolide treatment on such production in patients with DPB. METHOD: We performed Western blot analysis for MUC5AC of bronchoalveolar lavage fluid patients. Cases consisted of four groups including patients with DPB, idiopathic pulmonary fibrosis (IPF), and sarcoidosis, and healthy volunteers. RESULTS: MUC5AC was detected in DPB patients but not in other groups. Macrolide treatment tended to inhibit such production in DPB patients. CONCLUSIONS: Our results suggest that overproduction of MUC5AC plays an important role in the pathogenesis of DPB.
No takes yet. Share an insight, caveat, or question.
Kaneko et al. (2003) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: